Intravacc to In-license CimCure’s iBoost Technology, Expanding its Vaccine Platform Portfolio Read more
Daiichi Sankyo Expands DS-1062 Study to Include Patients with Triple Negative Breast Cancer Read more
Aligos Therapeutics and KU Leuven Announce Collaboration for the Development of a Therapeutic Candidate Targeting Coronavirus Read more
FDA Grants ODD for Prestige BioPharma’s PBP1510 Anti-PAUF Monoclonal Antibody for the Treatment of Pancreatic Cancer Read more
FDA Approves BAVENCIO as First-Line Maintenance Treatment for Patients with Locally Advanced or Metastatic Urothelial Carcinoma Read more